Approval · Notice of Compliance 5541 · 2004
LIBRAX: Notice of Compliance 5541
Issued September 28, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5541
- Date
- September 28, 2004
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anxiolytic, anticholinergic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIBRAX | 00115630 | Marketed |
Medicinal ingredients
- CHLORDIAZEPOXIDE HCL 5 MG per CAP
- CLIDINIUM BROMIDE 2.5 MG per CAP